Amphastar Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
If you work at Amphastar Pharmaceuticals Inc and you wish to licence your ESG aseessment, please get in touch. The report of Amphastar Pharmaceuticals Inc is assembled by All Street Sevva using proprietary artificial intelligence. Other companies in the rating industry group for Amphastar Pharmaceuticals Inc are displayedin the table.
Amphastar Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.2; made up of an environmental score of 6.0, social score of 4.8 and governance score of 4.8.
5.2
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
658 | Transchem Ltd | 5.3 | High |
658 | Zenith Healthcare Ltd | 5.3 | High |
687 | Amphastar Pharmaceuticals Inc | 5.2 | High |
687 | Cardiol Therapeutics Inc | 5.2 | High |
687 | Cell Source Inc | 5.2 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Amphastar Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Does Amphastar Pharmaceuticals Inc disclose current and historical energy intensity?
Does Amphastar Pharmaceuticals Inc report the average age of the workforce?
Does Amphastar Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Does Amphastar Pharmaceuticals Inc disclose its ethnicity pay gap?
Does Amphastar Pharmaceuticals Inc disclose cybersecurity risks?
Does Amphastar Pharmaceuticals Inc offer flexible work?
Does Amphastar Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Amphastar Pharmaceuticals Inc disclose the number of employees in R&D functions?
Does Amphastar Pharmaceuticals Inc conduct supply chain audits?
Does Amphastar Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Amphastar Pharmaceuticals Inc conduct 360 degree staff reviews?
Does Amphastar Pharmaceuticals Inc disclose the individual responsible for D&I?
Does Amphastar Pharmaceuticals Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Amphastar Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Does Amphastar Pharmaceuticals Inc disclose water use targets?
Does Amphastar Pharmaceuticals Inc have careers partnerships with academic institutions?
Did Amphastar Pharmaceuticals Inc have a product recall in the last two years?
Does Amphastar Pharmaceuticals Inc disclose incidents of discrimination?
Does Amphastar Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Has Amphastar Pharmaceuticals Inc issued a profit warning in the past 24 months?
Does Amphastar Pharmaceuticals Inc disclose parental leave metrics?
Does Amphastar Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Does Amphastar Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Amphastar Pharmaceuticals Inc disclose the pay ratio of women to men?
Does Amphastar Pharmaceuticals Inc support suppliers with sustainability related research and development?
Does Amphastar Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Amphastar Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Amphastar Pharmaceuticals Inc involved in embryonic stem cell research?
Does Amphastar Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Does Amphastar Pharmaceuticals Inc disclose its waste policy?
Does Amphastar Pharmaceuticals Inc report according to TCFD requirements?
Does Amphastar Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Amphastar Pharmaceuticals Inc disclose energy use targets?
Does Amphastar Pharmaceuticals Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Amphastar Pharmaceuticals Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Amphastar Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers procainamide for documented ventricular arrhythmias; neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; medroxyprogesterone acetate injectable suspension for the prevention of pregnancy; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block, as well as manufactures and distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.